MARY TOAL: Open Payments
NPI 1437398278 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$484 in 28 payments from 10 companies in 2025. Trend: 2023 $501 · 2024 $282 · 2025 $484
Food & beverage: $385Education: $99
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $150 |
| Novartis Pharmaceuticals Corporation | 4 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $55 |
| ABBVIE INC. | 3 | $52 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| Amgen Inc. | 1 | $29 |
| LEO Pharma Inc. | 1 | $24 |
| UCB, Inc. | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $19 |
Products named: Sotyktu, SPEVIGO, DUPIXENT, COSENTYX, OTEZLA, ANZUPGO, Bimzelx, TREMFYA.
Industry payments across OH — which companies pay providers there.
